AzTrials
AzTrials

Lung CancerPhase 1/2SESNCT01786187

The Symptom Experience Study in Persons With Non-Small Cell Lung Cancer

A Phase 1/2 study testing Light Physical Activity and Symptom Experience Report in people with Lung Cancer, run by Michigan State University at 4 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Little is known about the symptom experience of persons having undergone surgery for lung cancer. What we do know is that symptoms are common and can become severe and lasting. The main purpose of this study is two-fold: 1. Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Lung Cancer
What is being tested?
Light Physical Activity and Symptom Experience Report
Could I receive a placebo?
No, everyone receives an active treatment
How many people
87 participants
Where
4 sitesUnited States
Study dates
Jan 2013to Oct 2014
Phase
Phase 1/2
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women and men at least 21 years of age with suspected NSCLC to be confirmed after surgery.
  • Planned surgical resection, not diagnostics alone, for treatment of suspected non-small cell lung cancer (NSCLC) to include such surgical approaches as open thoracotomy, video assisted thoracic surgery (VATS), and Robotic procedures.
  • Karnofsky Performance Status score of at least 70%.
  • Thoracic surgeon approval pre- and post-surgery.
  • Medically stable co-morbid conditions including cardiovascular disease such as post-myocardial infarction, stable coronary bypass graft surgery, and stable percutaneous transluminal coronary angioplasty; and mild to moderate cardiopulmonary obstructive disease.
  • Has phone access capability.
Show all 10Show fewer
  • Able to speak and write English.
  • Able to hear and speak for phone interviews.
  • Owns a television.
  • Lives within 1.5 hours driving distance of recruitment site.

Who cannot join

  • Severe impairment in seeing, hearing, and speaking.
  • Uncontrolled co-morbid conditions such as cardiac or pulmonary disease.
  • Uncontrolled hypertension.
  • Active treatment for malignancy within the past six months (other than non-melanoma skin cancer and when undergoing long-term hormonal treatment for common cancers such as breast and prostate cancer where disease is stable).
  • Presence of metastatic disease.
  • Requires portable oxygen therapy for activities of daily living.
Show all 12Show fewer
  • Weight greater than 330 pounds (weight capacity of the Wii balance board).
  • History of photosensitive seizures.
  • Any condition or disorder that would impede safe participation as directed.
  • Plans to relocate outside the study area during the study period or unable to fully participate.
  • Diagnosed dementia.
  • Video-assisted thoracic surgery (VATS) procedure.

Trial locations and contacts

4 sites in 1 country.

United States4 sites
  • Michigan State University

    East Lansing, Michigan, 48824

  • Sparrow Hospital

    East Lansing, Michigan, 48912

  • West Michigan Cardiothoracic Surgeons

    Grand Rapids, Michigan, 49503

  • McLaren Greater Lansing, Greenlawn Campus

    Lansing, Michigan, 48910

Other trials in United States

About this study

Official title: Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience

Little is known about the symptom experience of persons having undergone surgery for lung cancer. What we do know is that symptoms are common and can become severe and lasting. The main purpose of this study is two-fold:

  1. To better understand the symptom experience of persons with lung cancer prior to surgery and for up to six weeks after returning home from the hospital.
  2. To examine the role of a light physical activity program in persons who are undergoing surgery for lung cancer for the treatment of a specific symptom.
Read more

The goals of this study include:

  • Collecting information about the participant's current and prior health history, symptoms, and health-related quality of life.
  • Assessing our ability to recruit participants to the study.
  • Assessing participant's level of participation.
  • Evaluating the participant's satisfaction with the program.

We expect that patients after undergoing surgery for lung cancer during the recovery process will experience multiple symptoms. We also expect to find that a light intensity physical activity program will be feasible, acceptable, and show a positive impact on symptoms such as cancer-related fatigue and confidence for cancer-related fatigue self-management.

Information gained from this randomized controlled trial study will be used to refine the design of future larger-scale studies targeting symptoms such as cancer-related fatigue for the lung cancer population.

Read the detailed description

Study Procedures:

Participants will be randomly assigned (like flipping a coin) to one of the following groups upon completion of collection of initial information about the participant's: current and prior health history, symptoms, and health-related quality of life, and take a 6-minute self-paced walking test to measure walking ability. This test will occur at Spectrum Health facility before surgery.

Groups: 1) The Symptom Experience Group and the 2) Light Physical Activity Group

Description of the Symptom Experience Group:

In addition to receiving conventional treatment for your cancer, as prescribed by your health care providers, you will receive planned, structured, weekly telephone visits to report the experience of your symptoms and health-related quality of life questions.

In the Symptom Experience Group you will:

  • Provide information about your current and prior health history.
  • Take a 6-minute self-paced walking test to measure your walking ability at Spectrum Health facility before surgery and at approximately 6-weeks after returning home from the hospital (prior to possible chemotherapy and/or radiation therapy).
  • Wear a pedometer each day of the study and record the number of steps you take each day.
  • Contact the nurse researcher if you have any study related questions.
  • Record information and comments in a daily diary (takes approximately 2 minutes to complete each day) and answer research questions via a weekly telephone visit throughout the study.

If you wish to take part in this study you will need to:

  • Keep your study appointments.
  • Tell your telephone research assistant about any medications you are taking.
  • Tell your telephone research assistant about any side effects, doctor visits, or hospitalizations that you may have whether or not you think they are related to the study.

In the Symptom Experience Group you will receive:

  • Program education prior to surgery.
  • A telephone visit within 3 days (24 hours is optimum) after being discharged from the hospital to ask questions about your health with the interview taking approximately 30 minutes.
  • The health interview can be rescheduled for completion within 3 days of hospital discharge should you not feel well enough to complete the interview.
  • At the end of weeks 1-6, we will make a telephone visit to complete health questionnaires with most interviews taking 15 minutes except on weeks 3 and 6 taking approximately 30 minutes.
  • Upon completion of your participation in the Symptom Experience Group, you will receive information regarding the light physical activity program.
  • Upon completion of the study, you will be provided an overview of the results of the study.

Description of the Light Physical Activity Group:

In addition to receiving conventional treatment for cancer, as prescribed by your health care providers, you will receive a home-based light physical activity program to help you manage a specific symptom related to cancer and cancer treatment.

In the Light Physical Activity Group you will:

  • Provide information about your current and prior health history.
  • Take a 6-minute self-paced walking test to measure your walking ability at a Spectrum Health facility before surgery and at approximately 6-weeks after returning home from the hospital (prior to possible chemotherapy and/or radiation therapy).
  • Participate in a self-scheduled, home-based physical activity program to help you learn how to manage a specific symptom related to cancer and cancer treatment for a total of six weeks following your return home from the hospital.
  • Participate in a time commitment starting at 5 minutes a day 5 days a week gradually increasing to 30 minutes a day 5 days a week as able by week 6.
  • Wear a pedometer each day of the study and record the number of steps you take each day.
  • Record information and comments in a daily diary (takes approximately 2 minutes to complete each day) and answer research questions via a weekly telephone visit throughout the study.
  • Contact the nurse researcher if you have any study related questions. If you wish to take part in this study you will need to:
  • Keep your study appointments.
  • Tell your nurse about any medications you are taking.
  • Tell your nurse about any side effects, doctor visits, or hospitalizations that you may have whether or not you think they are related to the study.

In the Light Physical Activity Group you will receive:

  • Program education prior to surgery.
  • A telephone visit from a nurse within 3 days (24 hours is optimum) after being discharged from the hospital to:
  • Ask questions about your symptoms to see if you are ready to start light physical activity program taking approximately 5 minutes.
  • If you are ready, we will arrange a home visit within 4 days of discharge.
  • If not ready, we will contact your surgeon to help you and call you each day to assess if you are ready to start.
  • A telephone visit from a research assistant within 3 days (24 hours is optimum) after being discharged from the hospital to:
  • Ask questions about your health with the interview taking approximately 30 minutes.
  • The health interview can be rescheduled for completion within 3 days of hospital discharge should you not feel well enough to complete the interview.
  • The first home visit from the nurse after surgery will take approximately 2 hours and the nurse will:
  • Assemble and teach you how to operate the physical activity equipment.
  • Assist you in completing your first physical activity on this day.
  • Follow-up your first home visit with a telephone visit within 24 hours to answer any questions and concerns about the program.
  • At the beginning of week two, the nurse will make one more home visit, and at the beginning of weeks 3-6 the nurse will make a telephone visit to collect and review your recorded information.
  • The nurse will be available to make additional home and telephone visits should you need assistance.
  • At the end of weeks 1-6, research staff will make a telephone visit to complete the health questionnaires with most interviews taking 15 minutes except on weeks 3 and 6 taking approximately 30 minutes.

We expect 86 persons, 21 years of age or older who are scheduled for surgery to treat lung cancer from the west Michigan area to participate in the study.

The potential risks for the Symptom Experience and Light Physical Activity Groups Include:

Risks associated with the six-minute walk test are considered low. The study may involve risks to you which are currently unknown or unforeseeable. Risks may include and are not limited to:

  • You may stumble or fall, get short of breath, experience muscle cramps, nausea, chest pain, and abnormal blood pressure.
  • The walk test is self-paced by the participant for six-minutes and will be stopped if you want it to be stopped.

The potential risks of this study for the Light Physical activity Group Include:

  • The light physical activity program as prescribed in this study corresponds to normal every day activities that are mildly exerting and pose no greater challenge than normal activities of daily living such as:
  • Strolling slowly in your home or at work. Grocery shopping.
  • Performing light work in the house such as making a bed, washing dishes, preparing food, dusting, and carrying out the trash.
  • Riding a lawn mower to mow the lawn or walking applying seed or fertilizer to the lawn.
  • Walking in the mall; Bird watching.
  • The development or increase of activity-dependent symptoms such as fatigue or muscle or joint soreness.
  • The reaction to the body to physical activity cannot always be predicted with accuracy and there is a risk of falling while walking and/or standing in place.
  • As part of the program involves the use of your television, some people (1 in 4,000) may have seizures or blackouts triggered by light flashes or patterns while they are watching television or playing such things as video games even if they haven't had a seizure before.
  • The reaction of the body to physical activity cannot always be predicted with accuracy so safety procedures are being provided to each participant prior to participation. Safety procedures include but are not limited to:
  • Following your physical activity prescription and safety procedures.
  • Using tools to monitor your heart rate such as through a heart rate wristwatch monitor.
  • Telephone access available during light physical activity.
  • Accessing your nurse researchers if you have a concern.

Potential Benefits of the Study:

We cannot promise any benefits to you or others from your taking part in this research. It is hoped that what is learned in this study may benefit other lung cancer patients in the future. If you agree to take part in this study you will receive results of this study in the future following study completion. We will notify you if any significant new findings develop during the course of the study which might affect your willingness to participate.

The potential benefits of being in the Light Physical Activity Group may include:

  • Increased ability to manage a symptom related to cancer and its treatment.
  • Increased ability in performing day-to-day activities.
  • Increased heart and lung (cardiorespiratory) fitness.
  • Receiving symptom management help from professional registered nurses.
  • Feeling more in control of your symptoms.
Conditions
Lung Cancer
Being tested
Light Physical Activity, Symptom Experience Report
Keywords
Lung Cancer, Symptoms
Medical subject headings
Lung Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Light Physical ActivityBehavioural

    Conventional treatment for cancer as prescribed by the participant's health care providers and will receive a home-based light physical activity program to help manage a specific symptom related to cancer and cancer treatment.

  • Symptom Experience ReportOther

    Conventional treatment for cancer as prescribed by the participant's health care providers and will receive planned, structured, weekly telephone visits to report the experience of symptoms and health-related quality of life information.

Study groups in NCT01786187
Study groupRoleWhat they receive
Symptom Experience GroupActive comparatorConventional treatment for cancer as prescribed by the participant's health care providers and will receive planned, structured, weekly telephone visits to report the experience of symptoms and health-related quality of life information.
Receives: Other: Symptom Experience Report
Light Physical Activity GroupExperimentalConventional treatment for cancer as prescribed by the participant's health care providers and will receive a home-based light physical activity program to help manage a specific symptom related to cancer and cancer treatment.
Receives: Behavioral: Light Physical Activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determine Feasibility as Measured by Rates of Recruitment.

    Rates of recruitment were measured by the percentage of those eligible who enrolled.

    Measured: At the beginning of the study.

  2. Feasibility as Measured by Adherence.

    Adherence is the percentage of those adhering to the recommended exercise.

    Measured: 6-weeks.

  3. Feasibility as Measured by Retention.

    Retention is the percentage of those enrolled and completed and finished the program.

    Measured: 6-weeks.

  4. Feasibility as Measured by Adverse Events.

    Adverse Events is the percentage of participant's who had an adverse event.

    Measured: 6-weeks.

Secondary outcomes (1)
  1. Cancer-Related Fatigue Severity

    The range of the score was 0 to 10 with 10 meaning the worst cancer-related fatigue and zero meaning no cancer-related fatigue.

    Measured: At six weeks after discharge from the hospital after surgery for lung cancer.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2013 (estimated)
  2. Study startJan 2013
  3. Primary completionOct 2014
  4. Study completionOct 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
87 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01786187
Sponsor's protocol ID
R21CA164515
Other IDs
R21CA164515
Acronym
SES
Status last verified
Sep 2018
First submitted
2 Jan 2013
Last updated
25 Feb 2019
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Light Physical Activity and Symptom Experience Report in people with Lung Cancer, run by Michigan State University at 4 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 25 Feb 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determine Feasibility as Measured by Rates of Recruitment. (time frame: At the beginning of the study.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
SES Clinical Trial NCT01786187 | AzTrials